Mumbai: Shares in drug firm Saamya Biotech (India) Ltd listed on Friday at Rs 17.50 on the BSE, up 75 per cent from its initial public offer price of Rs 10 each.
The shares were trading at Rs 20 at 9:56 a.m., after touching a high of Rs 22, on volume of 165,161 shares.
The firm raised Rs 15 crore in the IPO to part-finance a drug manufacturing unit, its research and development work for biotechnology products and for working capital needs.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment